[Respiratory syncytial virus infections and preventive options]

MeSH terms

• Antibodies, Monoclonal / economics*
• Antibodies, Monoclonal / pharmacology
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Humanized
• Antiviral Agents / economics*
• Antiviral Agents / pharmacology
• Antiviral Agents / therapeutic use*
• Cost-Benefit Analysis
• Hospitalization / economics
• Humans
• Infant
• Multicenter Studies as Topic
• Netherlands / epidemiology
• Palivizumab
• Product Surveillance, Postmarketing
• Respiratory Syncytial Virus Infections / economics
• Respiratory Syncytial Virus Infections / epidemiology
• Respiratory Syncytial Virus Infections / prevention & control*
• United States